Tue, 10 Dec 2024 | BUSINESS SALE
Two pharmacies in Derbyshire with a century of history between them have been bought out of administration by a regional pharmacy chain.
Dents of Chesterfield and Dents Pharmacy, trading under the John Dent (Chemist) name, fell into administration in late 2023. Together, the pharmacies with over 100 years of trading history dispensed an average of 16,000 items per month.
According to its last set of accounts filed with Companies House, John Dent (Chemist) made a loss of £167,573 in the year to September 30th, 2022, with net current liabilities of £262,615 and cash available of £69,592.
At the time it employed approximately 14 staff.
However, under a deal brokered by property adviser Christie & Co, the pharmacies have been bought by Sachin Tammewar of SSS Healthcare, a multiple pharmacy operator based in South Yorkshire which now owns five branches.
Carl Steer, director – pharmacy at Christie & Co, said “It is always regrettable to see any business enter administration but more so with such a long-established brand. We were tasked with attracting a buyer on the best terms as soon as possible and quickly gained multiple offers."
He added that the pharmacy sales market has proven resilient across the Midlands in 2024, with Christie & Co achieving a record performance in terms of sales. He expects further sales activity ahead.
“Sales have been well-represented across every type and size from independent sellers of one business through to our successful sale of numerous pharmacies sold as part of Project Echo for a national operator,” he said. “As we go into 2025, we expect more operators seeking to sell from the independent sector, which will be well-served by our large database of first-time buyers and acquisitive small-medium sized groups seeking new opportunities.”
John Dent (Chemist) Ltd was sold for an undisclosed price.
Find out more about how to find and buy distressed assets
Opportunity to acquire a highly reputable residential home care service provider in Sussex, known for exceptional care quality.
Owner operated for over 20 years, this business has built up a strong reputation in the London borough it operates in. The company has a contract worth up to £12 million, which has been extended to 2025.
This is a unique chance to acquire a scalable microbiology testing and consultancy business with strong ties to both private and NHS healthcare facilities across the UK. With significant growth potential and a wealth of expertise, this fully relocata...
RELOCATABLE
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.